Last reviewed · How we verify

Viral vector vaccine booster

Universidad del Desarrollo · Phase 2 active Small molecule

Viral vector vaccine booster is a Small molecule drug developed by Universidad del Desarrollo. It is currently in Phase 2 development. Also known as: ChAdOx1.

At a glance

Generic nameViral vector vaccine booster
Also known asChAdOx1
SponsorUniversidad del Desarrollo
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Viral vector vaccine booster

What is Viral vector vaccine booster?

Viral vector vaccine booster is a Small molecule drug developed by Universidad del Desarrollo.

Who makes Viral vector vaccine booster?

Viral vector vaccine booster is developed by Universidad del Desarrollo (see full Universidad del Desarrollo pipeline at /company/universidad-del-desarrollo).

Is Viral vector vaccine booster also known as anything else?

Viral vector vaccine booster is also known as ChAdOx1.

What development phase is Viral vector vaccine booster in?

Viral vector vaccine booster is in Phase 2.

Related